Literature DB >> 19609781

[G-DRG system 2009: relevant changes for rheumatology].

W Fiori1, A Liedtke-Dyong, H-J Lakomek, K Buscham, H Lehmann, W Liman, A-K Fuchs, F Bessler, N Roeder.   

Abstract

The following article presents the main general and specific changes in the G-DRG (German diagnosis-related groups) system in terms of the classification systems for diagnoses and procedures as well as the billing process for 2009. Of fundamental relevance is the national weighting of the G-DRG I97Z (complex rheumatologic treatment), which up to now had to be negotiated individually by each hospital. Emphasis is also put on case auditing by the health insurers. Being primarily a tool for redistribution of resources, every hospital has to analyze the economic effects of the 2009 G-DRG system by applying the G-DRG transition grouper to its own cases. Depending on their clinical focus rheumatological departments may experience positive or negative consequences from the development. The strain imposed on hospitals by inadequate refunding of rising costs has to be assessed separately from the effects of redistribution by the G-DRG system.

Mesh:

Year:  2009        PMID: 19609781     DOI: 10.1007/s00393-009-0501-z

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  3 in total

Review 1.  [Clinical pathways in rheumatological inpatient treatment - a structured process management].

Authors:  H-J Lakomek; J L Hülsemann; T Küttner; K Buscham; N Roeder
Journal:  Z Rheumatol       Date:  2007-05       Impact factor: 1.372

2.  Fibromyalgia syndrome: classification, diagnosis, and treatment.

Authors:  Winfried Häuser; Wolfgang Eich; Markus Herrmann; Detlev O Nutzinger; Marcus Schiltenwolf; Peter Henningsen
Journal:  Dtsch Arztebl Int       Date:  2009-06-05       Impact factor: 5.594

3.  [Clinical pathways: effective and efficient inpatient treatment].

Authors:  N Roeder; P Hensen; D Hindle; N Loskamp; H-J Lakomek
Journal:  Chirurg       Date:  2003-12       Impact factor: 0.955

  3 in total
  6 in total

1.  [The G-DRG System 2009--relevant changes for rheumatology].

Authors:  W Fiori; A Liedtke-Dyong; H-J Lakomek; K Buscham; H Lehmann; W Liman; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2010-05       Impact factor: 1.372

2.  [Hospital financing in 2015. Relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2015-06       Impact factor: 1.372

3.  [Hospital financing in 2013: relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372

4.  [Hospital financing in 2014. Relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

Review 5.  [Hospital financing in 2016. Relevant changes for rheumatology].

Authors:  W Fiori; H Bunzemeier; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

Review 6.  [Complex treatments in rheumatology and geriatrics - Challenges - Differences - Chances].

Authors:  H-J Lakomek; W Fiori
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.